Risk of diabetes mellitus associated with atypical antipsychotic use among patients with bipolar disorder: A retrospective, population-based, case-control study.
about
Side effects of atypical antipsychotics: a brief overviewOne-year risk of psychiatric hospitalization and associated treatment costs in bipolar disorder treated with atypical antipsychotics: a retrospective claims database analysis.Use pattern and off-label use of atypical antipsychotics in bipolar disorder, 1998-2002Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care.Patterns of initiation of second generation antipsychotics for bipolar disorder: a month-by-month analysis of provider behavior.Implementing composite quality metrics for bipolar disorder: towards a more comprehensive approach to quality measurementCardiovascular morbidity and mortality in bipolar disorder.Ziprasidone with adjunctive mood stabilizer in the maintenance treatment of bipolar I disorder: long-term changes in weight and metabolic profilesThe phenomenology of bipolar disorder: what drives the high rate of medical burden and determines long-term prognosis?Clinical Assessment of Weight Gain with Atypical Antipsychotics - Blonanserin vs AmisulprideSystematic Review and Meta-analysis of Pharmacological Interventions for Weight Gain from Antipsychotics and Mood Stabilizers.Influence of the drug exposure definition on the assessment of the antipsychotic metabolic impact in patients initially treated with mood-stabilizers.Oxcarbazepine as monotherapy of acute mania in insufficiently controlled type-1 diabetes mellitus: a case-report.Effect of Psychotropic Drugs on Development of Diabetes Mellitus in Patients With Alzheimer's DiseaseMetabolic syndrome in bipolar disordersAssociations between comorbid anxiety, diabetes control, and overall medical burden in patients with serious mental illness and diabetes.Metabolic syndrome and insulin resistance in schizophrenia patients receiving antipsychotics genotyped for the methylenetetrahydrofolate reductase (MTHFR) 677C/T and 1298A/C variants.Neurobehavioral assessment in forensic practiceElevated prevalence of obesity, metabolic syndrome, and cardiovascular risk factors in bipolar disorderMisclassification in assessment of diabetogenic risk using electronic health records.Manic/hypomanic symptom burden and cardiovascular mortality in bipolar disorder.Diabetes is associated with lower global cognitive function in schizophreniaAssociations among comorbid anxiety, psychiatric symptomatology, and diabetic control in a population with serious mental illness and diabetes: Findings from an interventional randomized controlled trial.Achievement of Adequate Glycemic Control in Patients With Type 2 Diabetes and Comorbid Mental Health Conditions Treated in a Primary Care Setting.
P2860
Q24642721-51B7ABF5-5451-4D7D-BF1B-2AA622926B16Q33788485-6627B5AB-E25D-480C-AE42-A5323554C707Q33932148-C1C7EF2E-AD1D-4988-A8A6-F6E400E756E8Q34623350-4A514AFC-466C-487A-8E80-C451EBFBF78DQ34636572-369C2082-3C6E-4250-91CA-581671C8DD61Q34905003-04834E1A-C0B3-402B-A676-5A2EC5628D47Q35313130-C2774F90-6F98-485A-9FCE-B001BFC9D275Q35577365-9ACD608B-EECE-43D4-8FE9-49F105F20407Q35841353-9FAF0D60-10AE-4DDA-83A5-2827104441BEQ35918105-4E427A63-D4E1-4F14-B95A-F8EEEF046D28Q36034676-D971B8CA-2050-4164-BA11-A01B7EFE18AFQ36088018-4A40421E-23E7-4C12-91C9-897BB20AECECQ36166185-3AECB0D7-B62A-4B2B-B7DD-19CE26B3983EQ36194233-BE2FF019-E88F-4CC4-A23C-0C86C2FFEFB8Q36400968-9DCCA8AE-7159-4E9E-9041-8731C625E2D0Q36424084-350CEAC1-9D57-411C-83EC-7FD385478343Q36503217-26022C9E-6AAB-482B-B3FE-E4DAB6F8E872Q36825028-90A512C7-6FC3-47DA-AE00-E0CFB3481EDDQ37218782-830EBB1E-11EB-4E9E-81D4-E2B93C403648Q37233836-57A3C137-4B3D-40BA-8854-D64B1C4AD079Q37426682-F9477F2D-6BEC-4FA0-9E2F-5BD171B2FAC6Q37731448-EBAC4D49-E439-4E27-A94E-7CDA7AA4A67CQ47244549-464E45C4-11FC-4E4D-B6E8-21EE17351D89Q47573164-92088636-08F6-4907-BD86-5EF8ADC3A7D1
P2860
Risk of diabetes mellitus associated with atypical antipsychotic use among patients with bipolar disorder: A retrospective, population-based, case-control study.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Risk of diabetes mellitus asso ...... ion-based, case-control study.
@en
Risk of diabetes mellitus asso ...... ion-based, case-control study.
@nl
type
label
Risk of diabetes mellitus asso ...... ion-based, case-control study.
@en
Risk of diabetes mellitus asso ...... ion-based, case-control study.
@nl
prefLabel
Risk of diabetes mellitus asso ...... ion-based, case-control study.
@en
Risk of diabetes mellitus asso ...... ion-based, case-control study.
@nl
P2093
P356
P1476
Risk of diabetes mellitus asso ...... tion-based, case-control study
@en
P2093
Dongming Jiang
Gilbert J L'Italien
Jeff J Guo
Patricia K Corey-Lisle
Paul E Keck
Raymond Jang
P304
P356
10.4088/JCP.V67N0707
P577
2006-07-01T00:00:00Z